Krüger-Krasagakes S, Krasagakis K, Garbe C, Schmitt E, Hüls C, Blankenstein T, Diamantstein T
Institute of Immunology, Free University of Berlin, Germany.
Br J Cancer. 1994 Dec;70(6):1182-5. doi: 10.1038/bjc.1994.469.
The expression of interleukin 10 (IL-10) mRNA in human malignant melanoma was investigated by reverse transcriptase polymerase chain reaction analysis. Selective expression of IL-10 mRNA in tissues of primary melanomas and melanoma metastases was found in comparison with normal skin. In addition, strong expression of IL-10 mRNA and of biologically active IL-10 was detected in 3 out of 13 melanoma cell lines. Normal melanocytes consistently expressed low levels of IL-10 mRNA but did not produce detectable IL-10 protein, nor did keratinocytes or fibroblasts. The production of biologically active IL-10 by melanoma cell lines suggests that IL-10 mRNA in melanoma lesions may derive at least in part from the tumour cells themselves. Tumour-infiltrating cells, however, could also be a source of IL-10 in melanoma tissues. The presence of IL-10 in melanoma lesions may contribute to the postulated 'paralysis' of an anti-melanoma immune response.
通过逆转录聚合酶链反应分析研究了白细胞介素10(IL-10)mRNA在人恶性黑色素瘤中的表达。与正常皮肤相比,在原发性黑色素瘤和黑色素瘤转移灶组织中发现了IL-10 mRNA的选择性表达。此外,在13株黑色素瘤细胞系中的3株中检测到IL-10 mRNA和生物活性IL-10的强表达。正常黑素细胞始终表达低水平的IL-10 mRNA,但不产生可检测到的IL-10蛋白,角质形成细胞或成纤维细胞也不产生。黑色素瘤细胞系产生生物活性IL-10表明黑色素瘤病变中的IL-10 mRNA可能至少部分源自肿瘤细胞本身。然而,肿瘤浸润细胞也可能是黑色素瘤组织中IL-10的来源。黑色素瘤病变中IL-10的存在可能导致假定的抗黑色素瘤免疫反应“麻痹”。